Am J Pathol

1. OHTA Y, Kanamori Y, Maeda A, Saleh MF, et al
   Iron and Bile Acids Synergize to Exacerbate Congenital Cholestatic Liver Injury via Ferroptosis.
   Am J Pathol. 2026;196:700-715.
   

   >> Share

   
   

   
   Anticancer Res

2. MUTO H, Kuzuya T, Tachi Y, Nagano Y, et al
   Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab-Bevacizumab.
   Anticancer Res. 2026;46:1609-1618.
   

   >> Share

   
   
3. MOHRI K, Nagai H, Mukozu T, Matsui T, et al
   Clinical Utility of Tremelimumab/Durvalumab as First-line Treatment for Unresectable Hepatocellular Carcinoma: Serum Cytokine Profile Insights.
   Anticancer Res. 2026;46:1545-1556.
   

   >> Share

   
   
4. LIU Y, Cao J, Yu H, Sun Q, et al
   Dual Role of PSMB9 Linking Immune Activation and Tumor Adaptation in Hepatocellular Carcinoma With Therapeutic and Prognostic Implications.
   Anticancer Res. 2026;46:1389-1410.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

5. WANG W, Zhao Y, Li M, Wei M, et al
   Deep learning predicts and in vitro experiments validates the synergistic anti-liver cancer effect of vincristine and lenvatinib: Mechanism involving apoptosis induction via the TNF-alpha/Caspase-8 pathway.
   Biochem Biophys Res Commun. 2026;805:153380.
   

   >> Share

   
   
6. YANG S, Jingya L, Haijun C, Xiaobo W, et al
   Identification of pyroptosis-associated genes for the prediction of metabolic dysfunction-associated steatohepatitis based on interpretable machine learning models.
   Biochem Biophys Res Commun. 2026;809:153489.
   

   >> Share

   
   
7. KIM M, Kim MJ, Choi SK, Yu B, et al
   USP21-mediated SMARCB1 stabilization under hypoxia may influence tumor progression and immune response in HCC.
   Biochem Biophys Res Commun. 2026;805:153383.
   

   >> Share

   
   

   
   BMC Cancer

8. HELAL M, Gamal M, Basuni AA, El Gendy W, et al
   Relative telomer length as a potential biomarker in hepatocellular carcinoma: a comparative study of HCV patients treated with direct antiviral agent.
   BMC Cancer. 2026;26:295.
   

   >> Share

   
   

   
   BMC Gastroenterol

9. LU JC, Xiong ML, Cai ZQ, Mao T, et al
   Single-cell transcriptomic landscape of intrahepatic B Cells in MASH.
   BMC Gastroenterol. 2026 Feb 25. doi: 10.1186/s12876-026-04704.
   

   >> Share

   
   

   
   Dig Dis Sci

10. LEE SY, Lim CW, Kim S, Majeed UBA, et al
    Using the EVendo Score to Predict Varices and Varices Needing Treatment in Hepatocellular Carcinoma Patients Planned for Atezolizumab-Bevacizumab.
    Dig Dis Sci. 2026 Feb 26. doi: 10.1007/s10620-026-09776.
    

    >> Share

    
    

    
    Endoscopy

11. DOI T, Ishiwatari H, Ohba A, Sakamoto H, et al
    Preoperative bilateral drainage for perihilar cholangiocarcinoma via endoscopic ultrasound-guided hepaticogastrostomy using a novel side-hole plastic stent.
    Endoscopy. 2026;58.
    

    >> Share

    
    
12. YAMAMOTO Y, Mori H, Niida K, Tange M, et al
    Variceal transection with endoscopic submucosal dissection as a rescue therapy for esophageal varices with severe scarring.
    Endoscopy. 2026;58.
    

    >> Share

    
    
13. HARA H, Henta Y, Katsumata R, Matsumoto H, et al
    Non-dilation endoscopic ultrasound-guided hepaticoduodenostomy and hepaticogastrostomy using a 7-Fr delivery system.
    Endoscopy. 2026;58.
    

    >> Share

    
    
14. KODA H, Hara K, Ogata T, Haba S, et al
    Biliary network linkage using a side-hole-modified metal stent for concurrent endoscopic ultrasound-guided hepaticoduodenostomy.
    Endoscopy. 2026;58.
    

    >> Share

    
    
15. HANSSENS C, Dhondt E, Hindryckx P
    Endoscopic ultrasound-guided glue embolization to prevent hemorrhage after accidental tract formation to the portal venous system during hepaticogastrostomy.
    Endoscopy. 2026;58.
    

    >> Share

    
    

    
    Eur Radiol

16. YU C, Zhang Q, Ding JX, Li W, et al
    Large language model and Gd-EOB-DTPA-enhanced MRI-based risk stratification system for postoperative hepatocellular carcinoma: a multicenter study.
    Eur Radiol. 2026 Feb 23. doi: 10.1007/s00330-026-12424.
    

    >> Share

    
    

    
    Gastroenterology

17. WANG M, Chen F, Gao J, Liu Q, et al
    Clusterin Drives Fiber Endocytosis by Mesothelial Cells to Resolve Liver Fibrosis.
    Gastroenterology. 2026;170:569-583.
    

    >> Share

    
    
18. KATO S, Hikita H, Tsukamoto O, Sato K, et al
    Activation of the Integrin alphaV-YAP-CTGF Axis in Liver Sinusoidal Endothelial Cells Promotes Liver Fibrogenesis, Leading to Portal Hypertension and Liver Carcinogenesis in Congestive Hepatopathy.
    Gastroenterology. 2026 Feb 27:S0016-5085(25)06526.
    

    >> Share

    
    

    
    Gut

19. G FERNANDEZ-BARRENA M, McClain CJ
    Zinc-dependent post-transcriptional control of hepatocyte fate in and regeneration of alcohol-associated liver disease.
    Gut. 2026 Feb 26:gutjnl-2025-337941. doi: 10.1136/gutjnl-2025-337941.
    

    >> Share

    
    
20. CHANG YP, Chen YC, Liu CH
    Time-varying dynamics of hepatic steatosis and cardiometabolic risk: implications for posthepatitis C cure HCC risk.
    Gut. 2026 Feb 27:gutjnl-2026-338554. doi: 10.1136/gutjnl-2026-338554.
    

    >> Share

    
    

    
    Hepatology

21. CHEN S, Wan C, Yu C, Shen T, et al
    Dietary anthocyanins alleviates age-dependent hepatic steatosis by expanding Limosilactobacillus reuteri and modulating gut microbiota-bile acid-hepatic FXR signaling.
    Hepatology. 2026 Feb 24. doi: 10.1097/HEP.0000000000001721.
    

    >> Share

    
    
22. TOVOLI F, Iavarone M, Cabibbo G, Marra F, et al
    Long-term outcomes of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A real-world study.
    Hepatology. 2026 Feb 25. doi: 10.1097/HEP.0000000000001725.
    

    >> Share

    
    
23. HAGHNEJAD V, Burke L, El Ouahabi S, Parker R, et al
    Prediction models for liver decompensation in compensated advanced chronic liver disease: A systematic review.
    Hepatology. 2026;83:530-551.
    

    >> Share

    
    

    
    Indian J Gastroenterol

24. KOTHALKAR S
    Methodological concerns in evaluating beta-blockers use in during pregnancy in portal hypertension.
    Indian J Gastroenterol. 2026 Feb 27. doi: 10.1007/s12664-026-01982.
    

    >> Share

    
    
25. VERMA A, Giri S, Sahu SK, Priyadarshini S, et al
    Evaluation of spleen stiffness and liver stiffness as non-invasive predictors of esophageal varices in patients with cirrhosis of the liver.
    Indian J Gastroenterol. 2026 Feb 23. doi: 10.1007/s12664-025-01938.
    

    >> Share

    
    
26. PANDA K, Dash DP, Pattnaik B, Narayan J, et al
    Diagnostic performance of splenic stiffness measurement for prediction of esophageal/gastric varices in pediatric portal hypertension: A systematic review and meta-analysis.
    Indian J Gastroenterol. 2026 Feb 20. doi: 10.1007/s12664-025-01915.
    

    >> Share

    
    

    
    Int J Cancer

27. LAUKHUF J, Wiens L, Grozinger G, Dittmann H, et al
    Characterization of long-term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021.
    Int J Cancer. 2025 Nov 11. doi: 10.1002/ijc.70246.
    

    >> Share

    
    
28. YU C, Wan J, Jin C, Li C, et al
    Efficacy and safety of bronchial arterial infusion chemotherapy combined with transarterial chemoembolization and systemic therapy in hepatocellular carcinoma patients with lung metastases.
    Int J Cancer. 2026 Feb 25. doi: 10.1002/ijc.70405.
    

    >> Share

    
    

    
    J Clin Oncol

29. ZHU HD, Fan WJ, Zhao C, Wang S, et al
    Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial.
    J Clin Oncol. 2026 Feb 24:JCO2501796. doi: 10.1200/JCO-25-01796.
    

    >> Share

    
    

    
    J Comput Assist Tomogr

30. MENG Z, Lin M, Chu T, Zhu D, et al
    MRI Proton Density Fat Fraction From PET/MRI Elucidates the Biphasic Impact of Hepatic Steatosis on Liver 18F-FDG Uptake.
    J Comput Assist Tomogr. 2026 Feb 23. doi: 10.1097/RCT.0000000000001849.
    

    >> Share

    
    

    
    J Gastroenterol

31. SUN X, Zhang Y, Zhang X, Qin Q, et al
    Hepatocyte-specific yes-associated protein knockout exacerbates non-alcoholic steatohepatitis by upregulating PCSK9.
    J Gastroenterol. 2026 Feb 27. doi: 10.1007/s00535-026-02372.
    

    >> Share

    
    
32. LIU J, Jia T
    Letter to the editor to ''Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis''.
    J Gastroenterol. 2026 Feb 24. doi: 10.1007/s00535-026-02375.
    

    >> Share

    
    
33. ADNAN M, Khan S, Thasleem H, Imran J, et al
    IL-6 as a biomarker in atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.
    J Gastroenterol. 2026 Feb 21. doi: 10.1007/s00535-026-02360.
    

    >> Share

    
    
34. MYOJIN Y, Hikita H
    Growth differentiation factor 15: from stress response to clinical utility in chronic liver diseases.
    J Gastroenterol. 2026;61:117-130.
    

    >> Share

    
    
35. SHEN L, Lv T, Li S, Chen S, et al
    Factors associated with recompensation and criteria for etiological suppression in patients with primary biliary cholangitis.
    J Gastroenterol. 2026 Jan 13. doi: 10.1007/s00535-025-02342.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

36. LV E, Yao X, Jiang H
    Comment Letter: Toward Precision Medicine in Portal Hypertension: Insights From the Carvedilol Versus Propranolol Meta-Analysis.
    J Gastroenterol Hepatol. 2026 Feb 26. doi: 10.1111/jgh.70321.
    

    >> Share

    
    
37. LI X, Wu Z, He Z, Xu Y, et al
    The Impact of Hepatitis B Virus on the Tumor Microenvironment of Hepatocellular Carcinoma and Therapeutic Strategies.
    J Gastroenterol Hepatol. 2026 Feb 24. doi: 10.1111/jgh.70309.
    

    >> Share

    
    

    
    J Hepatol

38. OZDEN I
    Comment on "Serum procalcitonin: A novel tumor biomarker for ... fibrolamellar hepatocellular carcinoma" by Nault et.al.
    J Hepatol. 2026 Feb 25:S0168-8278(26)00087-5. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    
39. MARJOT T
    MASLD and breast cancer risk: The role of hepatocyte-derived exosomes.
    J Hepatol. 2026 Feb 23:S0168-8278(26)00001-2. doi: 10.1016/j.jhep.2025.
    

    >> Share

    
    

    
    J Pediatr Surg

40. POLITES SF, Vierkant RA, Aldrink JH, Lautz TB, et al
    Survival in children with hepatoblastoma and pulmonary metastatic disease at diagnosis based on extent of metastases and need for surgical clearance.
    J Pediatr Surg. 2026 Feb 24:163034. doi: 10.1016/j.jpedsurg.2026.163034.
    

    >> Share

    
    

    
    PLoS One

41. KHOSRAVI Z, Barzinpour F, Rabizadeh S, Nakhjavani M, et al
    Machine learning prediction of metabolic-associated fatty liver disease in type 2 diabetes: Emphasizing data imputation and feature selection.
    PLoS One. 2026;21:e0339580.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

42. MODANWAL G, Kumar S, Viswanathan V, Morin CE, et al
    Pediatric Personalized Deep Learning Models for Segmentation of Hepatoblastoma at CT and MRI.
    Radiol Imaging Cancer. 2026;8:e250041.
    

    >> Share

    
    
43. PAN Y, Ye R, Li J, Liu Y, et al
    Impact of Annotation Level on Multisequence MRI Models for Preoperative Microvascular Invasion Prediction in Hepatocellular Carcinoma.
    Radiol Imaging Cancer. 2026;8:e250407.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share